Digital render of Novo Nordisk's manufacturing expansion in Clayton, NC (Credit: Novo Nordisk)
June 24, 2024 02:15 PM EDTUpdated 06:08 PM
Manufacturing

No­vo Nordisk bud­gets $4.1B for new US man­u­fac­tur­ing site as it aban­dons plans for Irish build

Anna Brown

News Reporter

No­vo Nordisk is fur­ther boost­ing man­u­fac­tur­ing in the US for its obe­si­ty drugs as it in­jects $4.1 bil­lion for a sec­ond fill-fin­ish fa­cil­i­ty in Clay­ton …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Im­munol­o­gy biotech Alu­mis se­cures $250M in shrunk­en IPO

Au­toim­mune brain dis­ease start­up Ar­ialys gets new leader; In­tel­lia, Arv­inas ap­point CFOs

Sci­en­tists un­veil new way to make large changes to genes, and no CRISPR is re­quired

To tack­le a dead­ly brain dis­ease, sci­en­tists de­vise small but charm­ing epi­ge­net­ic edit­ing tool

Supreme Court nar­row­ly re­jects Pur­due bank­rupt­cy plan, says it gives Sack­lers too much pro­tec­tion

What Co­herus' $40M sale of its Hu­mi­ra biosim­i­lar says about the crowd­ed mar­ket

A service from the Financial Times